Evidence map›Paper›PMID 34357005›Full record

ArticleMedicina (Kaunas, Lithuania)2021

COVID-19 during Early Phase of Autologous Stem Cell Transplantation.

Sławomir Milczarek, Bartłomiej Baumert, Anna Sobuś, Ewa Wilk-Milczarek, Krzysztof Sommerfeld, Bogumiła Osękowska, Ewa Borowiecka, Edyta Paczkowska, Aleksandra Łanocha, Wojciech Poncyliusz and 2 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Sławomir MilczarekDepartment of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.ORCID 0000-0003-4445-6192
Bartłomiej BaumertDepartment of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.ORCID 0000-0001-9933-5844
Anna SobuśDepartment of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.
Ewa Wilk-MilczarekDepartment of General and Dental Radiology, Pomeranian Medical University, 70-111 Szczecin, Poland.
Krzysztof SommerfeldDepartment of Hematology and Transplantology, Pomeranian Medical University, 71-252 Szczecin, Poland.ORCID 0000-0002-4339-8106
Bogumiła OsękowskaDepartment of Hematology and Transplantology, Pomeranian Medical University, 71-252 Szczecin, Poland.ORCID 0000-0002-9348-8652
Ewa BorowieckaDepartment of Hematology and Transplantology, Pomeranian Medical University, 71-252 Szczecin, Poland.ORCID 0000-0001-5166-0234
Edyta PaczkowskaDepartment of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.ORCID 0000-0001-7052-9741
Aleksandra ŁanochaDepartment of Hematology and Transplantology, Pomeranian Medical University, 71-252 Szczecin, Poland.
Wojciech PoncyliuszDepartment of Diagnostic Imaging and Interventional Radiology, Pomeranian Medical University, 71-252 Szczecin, Poland.
Konrad JaroszDepartment of Anaesthesiology and Intensive Care, Pomeranian Medical University, 71-252 Szczecin, Poland.
Bogusław MachalińskiDepartment of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.
Pomeranian Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present one of few cases of COVID-19 occurrence during the early phase of autologous hematopoietic stem cell transplantation. We observed an interesting correlation between the patient's rapid clinical deterioration and myeloid reconstitution that cannot be assigned to engraftment syndrome. Our report emphasizes the need to investigate whether timely steroid therapy upon neutrophil engraftment in the setting of COVID-19 could limit the extent of lung injury and prevent ARDS. Furthermore, we discuss a significant issue of possible prolonged incubation of the virus in heavily pretreated hematological patients.

Indexed as

COVID-19Hematopoietic Stem Cell TransplantationHumansSARS-CoV-2Transplantation, AutologousAHSCTchemotherapyCOVID-19lymphoblastic lymphoma

Identifiers

PMID34357005
PMCPMC8303389
OpenAlexW3183756070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.